219 results
Page 3 of 11
6-K
EX-99.1
kilolh14wbsl3ljf
4 Aug 22
Purple Biotech Reports Second Quarter 2022 Financial Results
7:31am
6-K
EX-99.1
70c6w xi7jkery0
14 Jul 22
Purple Biotech Announces Executive Leadership Changes
7:31am
6-K
EX-99.1
zntgeetsmex
6 Jun 22
Report of Foreign Private Issuer
7:33am
6-K
EX-99.1
u7bq7
27 May 22
Report of Foreign Private Issuer
7:15am
6-K
EX-99.1
kbyoavz695b
18 May 22
Purple Biotech Announces the Initiation of Phase 2 Study for CM24 in 2L PDAC Patients
8:08am
6-K
x2hkr0f43sj6rm
18 May 22
Purple Biotech Announces the Initiation of Phase 2 Study for CM24 in 2L PDAC Patients
8:08am
6-K
EX-99.1
jx1h22w
12 May 22
Purple Biotech Reports First Quarter 2022 Financial Results
8:14am
6-K
g1mp1pfd5g2n6fks8j9a
2 May 22
Report of Foreign Private Issuer
4:10pm
6-K/A
EX-99.1
gxggnuqjxf3 6nsvgz
11 Apr 22
Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the American Association of Cancer Research 2022 Annual Meeting
4:10pm
S-8
5igp9cg
4 Apr 22
Registration of securities for employees
4:11pm
6-K
EX-99.1
w6a50 4037ef9
9 Feb 22
Purple Biotech Reports Second Half and Full-Year 2021 Financial Results
7:00am
6-K
EX-99.2
ap3t 2dmd
4 Feb 22
Purple Biotech Issues Letter to Shareholders
8:31am
6-K
EX-99.1
63ilk
4 Feb 22
Purple Biotech Issues Letter to Shareholders
8:31am
6-K
EX-99.1
bzsm8prr 0k
6 Jan 22
Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to its Board of Directors
7:31am
6-K
EX-99.1
tlmmujnu c2xwa0qp9i
9 Dec 21
Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer
7:30am
6-K
EX-99.1
yyrg 78gg7p0d5540jw
6 Dec 21
Report of Foreign Private Issuer
7:30am
6-K
EX-99.1
pxkk6
16 Nov 21
Report of Foreign Private Issuer
4:10pm
6-K
EX-99.1
9sdra85jrkybsge128bj
10 Nov 21
Notice of Annual General Meeting of Shareholders
4:45pm
6-K/A
aaoqh
9 Nov 21
Current report (foreign) (amended)
6:10am